LIONEX Information

LIONEX is developing novel Diagnostics for Tuberculosis and HIV based on a series of proprietary platforms. Our aim is to manufacture cost-effective but high quality, rapid tests for diseases endemic countries. LIONEX is ISO9001 and ISO13485 certified and has excellent, state-of-the art infrastructure including molecular biology CAT-I, and CAT-II laboratories with access to CAT-III labs. Manufacturing mashines and facilities for Large scale Lateral Flow Tests as In-Vitro-Diagnostics (IVD) are available at LIONEX. LIONEX cooperates with big pharma and large, international diagnostic companies for the development and production of diagnostic tests. We are highly active in the area of custom production of recombinant proteins in several expression systems including E.coli, Insect cells, B.subtilis, Lactococcus lactis, M.smegmatis. Our highly efficient expression systems and purification strategies enable us to produce 1-2 mg of recombinant proteins within 4-6 weeks for pilot experiments. If required, we can scale up the production to gram quantities for customers. LIONEX GmbH